Response to DA-EPOCH-R is associated with activation of 'fitter' cytotoxic T cells in patients with newly diagnosed double and triple hit high-grade B-cell lymphoma

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 109; no. 11; pp. 3760 - 3765
Main Authors De Jonge, A Vera, Bruins, Wassilis S C, Duetz, Carolien, Korst, Charlotte L B M, Rentenaar, Rosa, Cosovic, Meliha, Eken, Merve, Kersten, Marie-Jose, Sandberg, Yorick, Van Rijn, Rozemarijn S, Fijnheer, Rob, Mutsaers, Pim, Vergote, Vibeke K J, Issa, Djamila, Beeker, Aart, Bilgin, Yavuz M, Visser, Otto, Van Werkhoven, Erik, Roemer, Margaretha G M, Chamuleau, Martine E D, Mutis, Tuna
Format Journal Article
LanguageEnglish
Published Italy Fondazione Ferrata Storti 01.11.2024
Ferrata Storti Foundation
Subjects
Letter to the Editor
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Disclosures
MJK received research support from BMS/Celgene, Galapagos, Kite (a Gilead Company), Roche, and Takeda, and had an advisory role at Adicet Bio, Miltenyi Biotech, Novartis, and Roche. MEDC received research support from AbbVie, Genmab, BMS, and Gilead, and had an advisory role at AbbVie, Novartis, and Incyte. TM received research funding from Takeda, Janssen, and Genmab. All other authors have no conflicts of interest to disclose.
ISSN:0390-6078
1592-8721
1592-8721
DOI:10.3324/haematol.2024.285170